𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The significance of urokinase-type plasminogen activator, its inhibitors, and its receptor in ascites of patients with epithelial ovarian cancer

✍ Scribed by Setsuko K. Chambers; Robert E. Gertz Jr.; Christina M. Ivins; Barry M. Kacinski

Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
643 KB
Volume
75
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Clinical relevance of urokinase plasmino
Clinical relevance of urokinase plasminogen activator, its receptor, and its inhibitor in patients with renal cell carcinoma
✍ Rainer Hofmann; Antonie Lehmer; Markus Buresch; Rudolf Hartung; Kurt Ulm πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 559 KB

## BACKGROUND. Urokinase plasminogen activator (u-PA) plays a key role in the metastatic process by promoting plasmin mediated tissue degradation. Metastatic cell invasion requires localized proteolysis, which may be directed by u-PA receptor. The binding of u-PA and PAI-1 to the u-PA-receptor may

Cellular localization of urokinase-type
Cellular localization of urokinase-type plasminogen activator, its inhibitors, and their mRNAs in breast cancer tissues
✍ Umeda, Tomoko; Eguchi, Yutaka; Okino, Kouji; Kodama, Masashi; Hattori, Takanori πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 774 KB

The plasminogen activation (PA) system may participate in cancer invasion and metastasis. A series of breast cancer tissue specimens was analysed using in situ hybridization and immunohistochemistry. Urokinase-type plasminogen activator (u-PA) mRNA was detected in cancer cells and fibroblasts adjace

Urinary levels of urokinase-type plasmin
Urinary levels of urokinase-type plasminogen activator and its receptor in the detection of bladder carcinoma
✍ Roberto Casella; Shahrokh F. Shariat; Mara A. Monoski; Seth P. Lerner πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 75 KB πŸ‘ 1 views

## Background: The authors found previously that plasma levels of urokinase-type plasminogen activator (upa) and its receptor (upar) were elevated in patients with bladder carcinoma and were associated with features of biologically aggressive disease. in the current study, they tested the hypothesi